Steady state vascular imaging with extracellular gadobutrol: evaluation of the additional diagnostic benefit in patients who have undergone a peripheral magnetic resonance angiography protocol

Journal of Cardiovascular Magnetic Resonance

Henrik J Michaely²  Stefan O Schoenberg²  Lothar R Pilz¹  Katharina Hausotter²  Melissa M Ong² 

[1] Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany;Institute of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany

关键词: 3T;    Gadobutrol;    Venous imaging;    Vascular imaging;    Magnetic resonance angiography;    Steady state;   

Others  :  803648
DOI  :  10.1186/1532-429X-15-97

 received in 2013-04-06, accepted in 2013-09-18,  发布年份 2013

【 摘 要 】

Background

To evaluate the feasibility and additional diagnostic benefit of a high-resolution steady state 3D-volume interpolated breath-hold exam (VIBE) sequence between a continuous table movement (CTM) MR angiography of the entire runoff vasculature and a time-resolved (TWIST) MRA of the calves.

Methods

In this retrospective IRB approved study 224 patients (72 women, 152 men, mean age 67.29 ± 13.9) were included who had undergone a low-dose MR angiographic protocol at 3T (Siemens TimTrio) after injection of 0.1 mmol/kg gadobutrol including a CTM MRA, a time-resolved MRA of the calf station and a steady state 3D VIBE sequence prior to the time-resolved MRA. One board-certified radiologist rated the image quality of the steady state VIBE sequences on an ordinal three point scale (excellent, good, poor) and analyzed the images for additional diagnostic findings of and beyond the vascular system in comparison to the CTM MRA and the time-resolved MRA. Descriptive statistics and demographic patient data were used for further evaluation.

Results

The image quality of the steady state imaging of the pelvis, upper and lower leg was excellent in up to 88%, 84% and 47%, respectively, while poor image quality was only detected in the upper (2%) and lower leg (6%). An additional diagnostic benefit was found in 44% of the patients overall. The most common relevant pathologies included inflammatory processes of the soft tissues (26%), thrombi (14%), abscesses (13%) and tumors (11%). In subgroups of patients above the age of 60, 65, 70, 75 and 80 years an additional pathology was found in 50% 33%, 44%, 65% and 58%, respectively. There was no significant difference in terms of additional findings between men and women (46% and 39%, p > 0.05) and inpatients and outpatients (42% and 45%, p > 0.05).

Conclusion

Steady state imaging is also feasible with extracellular contrast agents with good image quality yielding additional diagnostic findings in up to 44% and above in patients older than 60 years of age irrespective of gender or patient status. Given the short acquisition time of 4 minutes this sequence could be added to all peripheral MRA exams.

【 授权许可】

   
2013 Ong et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

【 参考文献 】

• [1]Oser RF et al.. Accuracy of DSA in the evaluation of patency of infrapopliteal vessels. J Vasc Interv Radiol. 1995; 6(4):589-94.
• [2]Egglin TK et al.. Complications of peripheral arteriography: a new system to identify patients at increased risk. J Vasc Surg. 1995; 22(6):787-94.
• [3]Catalano C et al.. Infrarenal aortic and lower-extremity arterial disease: diagnostic performance of multi-detector row CT angiography. Radiology. 2004; 231(2):555-63.
• [4]Ouwendijk R et al.. Vessel wall calcifications at multi-detector row CT angiography in patients with peripheral arterial disease: effect on clinical utility and clinical predictors. Radiology. 2006; 241(2):603-8.
• [5]Menke J, Larsen J. Meta-analysis: accuracy of contrast-enhanced magnetic resonance angiography for assessing steno-occlusions in peripheral arterial disease. Ann Intern Med. 2010; 153(5):325-34.
• [6]Meaney JF et al.. Stepping-table gadolinium-enhanced digital subtraction MR angiography of the aorta and lower extremity arteries: preliminary experience. Radiology. 1999; 211(1):59-67.
• [7]Nielsen YW, Thomsen HS. Contrast-enhanced peripheral MRA: technique and contrast agents. Acta Radiol. 2012; 53(7):769-77.
• [8]Voth M et al.. Peripheral magnetic resonance angiography with continuous table movement in combination with high spatial and temporal resolution time-resolved MRA With a total single dose (0.1 mmol/kg) of gadobutrol at 3.0 T. Invest Radiol. 2009; 44(9):627-33.
• [9]Pereles FS et al.. Accuracy of stepping-table lower extremity MR angiography with dual-level bolus timing and separate calf acquisition: hybrid peripheral MR angiography. Radiology. 2006; 240(1):283-90.
• [10]Attenberger UI et al.. Peripheral arterial occlusive disease: evaluation of a high spatial and temporal resolution 3-T MR protocol with a low total dose of gadolinium versus conventional angiography. Radiology. 2010; 257(3):879-87.
• [11]Michaely HJ et al.. Feasibility of gadofosveset-enhanced steady-state magnetic resonance angiography of the peripheral vessels at 3 Tesla with Dixon fat saturation. Invest Radiol. 2008; 43(9):635-41.
• [12]Huppertz A et al.. Biphasic blood pool contrast agent-enhanced whole-body MR angiography for treatment planning in patients with significant arterial stenosis. Invest Radiol. 2009; 44(7):422-32.
• [13]Nikolaou K et al.. High-spatial-resolution multistation MR angiography with parallel imaging and blood pool contrast agent: initial experience. Radiology. 2006; 241(3):861-72.
• [14]Collins R et al.. Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review. BMJ. 2007; 334(7606):1257.
• [15]Nelemans PJ et al.. Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography. Radiology. 2000; 217(1):105-14.
• [16]Kramer JH, Grist TM. Peripheral MR angiography. Magn Reson Imaging Clin N Am. 2012; 20(4):761-76.
• [17]Dinter DJ et al.. Peripheral bolus-chase MR angiography: analysis of risk factors for nondiagnostic image quality of the calf vessels–a combined retrospective and prospective study. AJR Am J Roentgenol. 2009; 193(1):234-40.
• [18]Owen AR et al.. Critical lower-limb ischemia: the diagnostic performance of dual-phase injection MR angiography (including high-resolution distal imaging) compared with digital subtraction angiography. J Vasc Interv Radiol. 2009; 20(2):165-72.
• [19]Hooi JD et al.. Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease. The Limburg PAOD study. Peripheral arterial occlusive disease. Scand J Prim Health Care. 1998; 16(3):177-82.
• [20]Hooi JD et al.. Incidence of and risk factors for asymptomatic peripheral arterial occlusive disease: a longitudinal study. Am J Epidemiol. 2001; 153(7):666-72.
• [21]Hadizadeh DR et al.. Simultaneous MR arteriography and venography with blood pool contrast agent detects deep venous thrombosis in suspected arterial disease. AJR Am J Roentgenol. 2012; 198(5):1188-95.
• [22]Michaely HJ et al.. Intraindividual comparison of high-spatial-resolution abdominal MR angiography at 1.5 T and 3.0 T: initial experience. Radiology. 2007; 244(3):907-13.